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Abstract
Objectives To determine the correlation between CTmeasure-
ments of emphysema or peripheral airways and airflow ob-
struction in chronic obstructive pulmonary disease (COPD).
Methods PubMed, Embase and Web of Knowledge were
searched from 1976 to 2011. Two reviewers independently
screened 1,763 citations to identify articles that correlated
CT measurements to airflow obstruction parameters of the
pulmonary function test in COPD patients, rated study qual-
ity and extracted information. Three CT measurements were
accessed: lung attenuation area percentage<-950 Houns-
field units, mean lung density and airway wall area percent-
age. Two airflow obstruction parameters were accessed:
forced expiratory volume in the first second as percentage
from predicted (FEV1 %pred) and FEV1 divided by the
forced volume vital capacity.
Results Seventy-nine articles (9,559 participants) were in-
cluded in the systematic review, demonstrating different
methodologies, measurements and CT airflow obstruction
correlations. There were 15 high-quality articles (2,095 par-
ticipants) in the meta-analysis. The absolute pooled correla-
tion coefficients ranged from 0.48 (95 % CI, 0.40 to 0.54) to
0.65 (0.58 to 0.71) for inspiratory CT and 0.64 (0.53 to 0.72)
to 0.73 (0.63 to 0.80) for expiratory CT.
Conclusions CT measurements of emphysema or peripheral
airways are significantly related to airflow obstruction in
COPD patients. CT provides a morphological method to
investigate airway obstruction in COPD.
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Key Points
• Computed tomography is widely performed in patients
with chronic obstructive pulmonary disease (COPD)
• CT provides quantitative morphological methods to inves-
tigate airflow obstruction in COPD
• CT measurements correlate significantly with the degree of
airflow obstruction in COPD
• Expiratory CT measurements correlate more strongly with
airflow obstruction than inspiratory CT
• Low-dose CT decreases the radiation dose for diagnosis
and quantitative emphysema evaluation
Keywords Review, systematic . Meta-analysis .
Tomography, X-ray computed . Pulmonary disease, chronic
obstructive . Function test, pulmonary
Abbreviations
%LAA-950 Percentage of lung attenuation area
under -950 HU
Ai Airway lumen area
ATS American Thoracic Society
CC Correlation coefficient
CI Confidence interval
COPD Chronic obstructive pulmonary disease
CT Computed tomography
ERS European Respiratory Society
FEV1 %pred Forced expiratory volume in the first
second as percentage from predicted
FEV1/FVC FEV1 divided by the forced volume
vital capacity




MLD Mean lung density
Perc15 15 percentile point of lung density
PFT Pulmonary function test
PRISMA Preferred Reporting Items for Systematic
Reviews and Meta-analyses
QUADAS Quality Assessment of Diagnostic
Accuracy Studies
WA% Wall area percentage
WT Airway wall thickness
Introduction
Chronic obstructive pulmonary disease (COPD) is charac-
terised by airflow limitation that is not fully reversible [1].
The pathogenesis of airflow limitation in COPD is mainly
related to emphysema and small airway remodelling [2].
Although airflow obstruction parameters in the pulmonary
function test (PFT) by spirometry is essential in COPD
diagnosis, these parameters fail to quantify the proportionate
impact of emphysema and small airways disease individu-
ally. Morphological changes can be characterised and quan-
tified by computed tomography (CT), especially by multi-
detector CT [3]. For COPD patients, quantitative chest CTs
are important for understanding the pathogenesis and the
effect of therapeutic interventions [4], and can help to iden-
tify those most at risk for acute exacerbations [5]. Since the
introduction of the ‘density mask’ in 1988, CT emphysema
quantification has had a long history [6–8]. Multi-detector
CT can accurately evaluate emphysema [9]. However, quan-
tification of airway remodelling by CT is challenging be-
cause of its spatial resolution. Airway wall quantification
started over a decade ago, mainly for large airways [3], but
investigators have measured the peripheral airways down to
0.5-mm-lumen diameter [10] and 2.8 mm outer diameter
[11]. Measurement of narrowing of CT-detectable airways
may estimate the degree of small airways disease [10].
The assumption is that emphysema and peripheral airway
wall thickness, as detected by CT, are correlated to airflow
obstruction in COPD patients. Study results have been var-
iable and sometimes conflicting. However, some individual
studies have been small and underpowered [2, 12–15].
Therefore, we conducted a systemic review and meta-
analysis to determine the correlation between emphysema
or peripheral airway measurements on inspiratory and expi-
ratory CT, and airflow obstruction in COPD.
Materials and methods
This study was conducted according to Preferred Reporting
Items for Systematic Reviews and Meta-analyses (PRISMA)
[16].
Data sources and searches
We searched PubMed, Embase and Web of Knowledge from
January 1976 to December 2011, from the start of whole-
body CT, using terms related to computed tomography and
PFT (i.e. lung function*, respiratory function*, pulmonary
function*, etc.) and COPD (i.e. chronic obstructive pulmo-
nary disease*, chronic obstructive lung disease*, etc.) with-
out language restrictions (Electronic supplementary
Table 1). Unpublished studies were not included.
Study selection
Four reviewers with at least 6 years' experience in thoracic
radiology participated in the study selection. Each study was
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evaluated independently by two reviewers out of three, with
disagreements resolved by the fourth reviewer. Articles were
included in the systematic review if they: (1) analysed the
association between CT quantitative emphysema or airway
measurements and PFT; (2) investigated human beings; (3)
included participants diagnosed with stable adult COPD,
according to the Global initiative for chronic Obstructive
Lung Disease (GOLD) [1] or the American Thoracic Society
(ATS) or the European Respiratory Society (ERS), or clearly
defined similar criteria; (4) included participants who had
clearly described PFT, according to the guidelines of the
ATS, ERS or similar methods. Articles were excluded if they:
(1) were reviews, abstracts, case reports or letters; (2) were
laboratory or phantom studies; (3) covered participants with
confounding disease, such as interstitial lung disease, chronic
bronchitis, asthma and α-1 anti-trypsin disease.
Articles were subsequently included in the meta-analysis
if they: (1) had no selection bias (e.g. only mild or only
severe COPD); (2) had a sample size of ≥20 (20 subjects
would provide a power of 0.90 when detecting a typical
effect correlation coefficient of 0.60); (3) were performed
using volumetric multidetector CT; (4) reported correlation
coefficients; (5) reported the percentage of lung attenuation
area under -950 HU (%LAA-950), mean lung density
(MLD) or wall area percentage (WA%) in airways≥fifth
airway generation (sub-sub-segment level) as CT measure-
ments; (6) reported the predicted forced expiratory volume
in the first second as percentage (FEV1 %pred) and FEV1
divided by the forced volume vital capacity (FEV1/FVC) as
spirometry parameters. Studies were excluded if the CT
examination only included selected pulmonary levels or if
the slice increment was larger than the slice thickness. In
possible duplicate reports, the report with the largest sample
size was included.
Data extraction and quality assessment
Two reviewers evaluated independently, with disagreements
resolved by a third reviewer. A standardised extraction form
was used to collect study characteristics, participant charac-
teristics, methodology and correlation coefficients. The sys-
tematic review included ten CT measurements: %LAA-960,
%LAA-950, %LAA-910, %LAA-900, MLD, 15 percentile
point of lung density (Perc15), lung volume (LV), WA%,
airway wall thickness (WT) and airway lumen area (Ai).
Three CT measurements, %LAA-950, MLD and WA%
were pooled in the meta-analysis. Two PFT parameters for
airflow obstruction were collected, including FEV1 %pred
and FEV1/FVC.
Methodological quality and potential sources of bias of
the included meta-analysis articles were assessed with 14
standard items of the Quality Assessment of Diagnostic
Accuracy Studies (QUADAS) tool [17]. For each article, a
quality score was accumulated by assigning 1 point to each
fulfilled QUADAS item, 0.5 to unclear items and 0 to unmet
items. A score of ≥11 points was considered high quality
and a score <11 points as low quality. Cohen’sk was calcu-
lated to indicate inter-observer agreement. Publication bias
was evaluated with Begg and Mazumdar rank correlation,
Egger’s regression test and Rosenthal fail-safe n test.
Data synthesis and analysis
Summary measure was the correlation coefficient (CC).
Pooled CCs with 95 % confidence intervals (CIs) were
calculated using Hedges-Vevea random effects model and
Z-test for normality. Pooled CCs were calculated for the
correlations between %LAA-950 and FEV1 %pred,
%LAA-950 and FEV1/FVC, MLD and FEV1 %pred,
MLD and FEV1/FVC, and WA% and FEV1 %pred in inspi-
ratory and expiratory CT. If multi-level bronchi were eval-
uated, we chose the smallest bronchi. Heterogeneity was
tested using the Q statistic and I2 index. The random effects
model was used regardless of the heterogeneity test, al-
though results in the Q statistic were still stated. To inves-
tigate the impact of individual variables on the meta-
analysis results, subgroup analysis was performed if a sub-
group consisted of at least two studies. Subgroups were
based on radiation dose (low or normal dose) and breath-
hold procedure (inspiratory or expiratory). Meta-regression
was performed to investigate the influence of gender, if the
male percentage was reported by at least three studies.
Statistical analysis was performed using SPSS 18.0 (IBM,
NY, USA) and R 2.12.0 (R Foundation, Vienna, Austria). P
<0.05 was considered statistically significant.
Results
Study selection
The database searches elicited 1,763 citations (Fig. 1).
Seventy-nine articles were included in the systematic review
and 15 articles [13, 18–31] in the meta-analysis, including
10 [18–23, 25, 26, 28, 29] from trial cohorts.
Systematic review
The systematic review included 9,559 COPD participants
(range of mean age, 48 to 73 years), including 6,101
(63.8 %) men, 2,000 (20.9 %) women and 1,458 (15.3 %)
without indicated gender (Electronic supplementary Table 2).
A total of 6,935 (72.5 %) were (ex-)smokers and 133 (1.4 %)
non-smokers; for 2,491 (26.1 %) no smoking status was
reported. Fifty-four (68.4 %) studies were prospective and
23 (29.1 %) retrospective; in 2 (2.5 %) articles the study
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design was not reported. Forty-one (51.9 %) articles were
from Europe, 23 (29.1 %) from Asia and 15 (19.0 %) from
North America. Of the articles, 69 (87.3 %) were written in
English, 5 (6.3 %) in Italian, 3 (3.8 %) in Chinese, 1 (1.3 %) in
French and 1 (1.3 %) in Polish.
The tendency was towards larger sample size and more
advanced CTequipment in recent publications (Fig. 2). Before
2007, only articles with sample size <100 were found. After
2007, larger sample size articles were published. Although
single-slice CT (32 articles, 40.5 %) was continuously used
from 1993 to 2009, multi-detector CT has been popular in
recent years. Since 2002, 4- and 8-slice multi-detector CT (16
articles, 20.2 %) has been used. Since 2005, 16- and 64-slice
multi-detector CT (29 articles, 36.7 %) has been used.
Included articles varied in methodology. Volume acquisi-
tion was used in 36 articles (45.6 %) and non-volume acqui-
sition in 43 (54.4 %). Selected slices were acquired in 21
studies (26.6 %) and whole lung in 58 (73.4 %). Median slice
Fig. 1 Flowchart of literature
review and selection. COPD 0
Chronic obstruction pulmonary
disease; PFT 0 pulmonary
function test; MDCT 0 multi-
detector computed tomography
Fig. 2 Sample size of the
articles included in the
systematic review by year of
publication and CT generation.
MDCT 0 Multi-detector com-
puted tomography
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thickness was 1.0 mm (range, 0.625-10 mm). Median slice
increment was 2.0 mm (range, 0.625-20 mm). Low radiation
dose was used in 12 articles (15.2 %) and normal dose in 67
(84.7 %). Both inspiratory and expiratory CT findings were
evaluated in 24 articles (30.4 %), and only inspiratory in 54
articles (68.3 %) and expiratory in 1 article (1.3 %).
Sixty-four different CTmeasurements and 27 different PFT
parameters were reported (Electronic supplementary Figs. 4
and 5). Common CT measurements were %LAA-950 in 36
(45.6 %) studies, MLD in 22 (27.8 %), WA% in 17 (21.5 %)
and visual score in 17 (21.5 %). Common PFT parameters
were FEV1%pred in 72 articles (91.1%) and FEV1/FVC in 64
articles (81.0 %). Common lung parenchyma thresholds de-
fining emphysema ranged from -900 HU to -960 HU, with the
most commonly used threshold being -950 HU. In some
studies, different correlations to airflow obstruction parame-
ters in PFT were found with these differing thresholds in the
same sample [12, 14, 27, 32]. The CC between %LAA-950
and FEV1 %pred ranged from -0.67 to -0.09 [12, 13], between
MLD and FEV1 %pred from 0.18 to 0.85 [12, 33], between
WA% and FEV1 %pred from -0.713 to -0.044 [22, 34], be-
tween %LAA-950 and FEV1/FVC -0.75 to -0.09 [12, 35], and
between MLD and FEV1/FVC from 0.21 to 0.89 [12, 33]. In
four articles, the CC between Perc15 and FEV1 %pred in
inspiration ranged from 0.09 to 0.62, and the CC between
Perc15 and FEV1/FVC in inspiration from 0.12 to 0.62 [12,
13, 36, 37] (Electronic supplementary Table 3).
Risk of bias in the meta-analysis
All articles included in the meta-analysis were high quality
(Electronic supplementary Table 4 and Electronic supplemen-
tary Fig. 6). The quality score ranged from 12.5 to 13.5.
Suboptimal scores were present for three QUADAS items: 7
articles without an interval between CT and PFT (item 4), 9
articles without an indication whether CT quantification was
blinded to PFT (item 10) and 13 articles without an indication
whether PFT was blinded to CT quantification (item 11).
Cohen’sk was 0.925, expressing very good inter-observer
agreement. No publication bias was found (Electronic supple-
mentary Table 5). The median of Rosenthal fail-safe n was
122 (range, 84 to 614), indicating a solid empirical result.
Three of the nine meta-analysis calculations showed mild
heterogeneity. The I2 index was>50 % for the correlation
between MLD and FEV1 %pred in inspiration (P00.11, I
2
index050.6 %), between MLD and FEV1/FVC in inspira-
tion (P00.02, I2 index075.9 %), and between WA% and
FEV1 %pred (P00.04, I
2 index064.7 %).
Synthesis of results in the meta-analysis
The meta-analysis included 2,095 participants out of 9,559
in the systematic review (Fig.3).
Nine articles [13, 18, 19, 22–24, 26–28, 31] reported CC
between %LAA-950 and FEV1 %pred in inspiration. Two
[19, 25] were from the National Lung Screening Trial (NLST)
cohort and two [22, 23] from the Korean Obstructive Lung
Disease (KOLD) cohort. Because of possible duplicate report-
ing, articles [22, 25] with smaller sample sizes were excluded
from each cohort. The pooled CC between %LAA-950 and
FEV1 %pred was -0.48 (95% CI: -0.54, -0.40) in inspiration
and -0.64 (-0.72, -0.53) in expiration. The pooled CC between
%LAA-950 and FEV1/FVC was -0.65 (-0.71, -0.58) in inspi-
ration and -0.69 (-0.78, -0.59) in expiration.
No potential duplicate report was found for MLD. The
pooled CC between MLD and FEV1 %pred was 0.51 (95%
CI: 0.38, 0.63) in inspiration and 0.71 (0.58, 0.81) in expira-
tion. The pooled CC between MLD and FEV1/FVC was 0.64
(0.52, 0.74) in inspiration and 0.73 (0.63, 0.80) in expiration.
Seven articles [18, 20–22, 25, 28, 30] reported CC be-
tween WA% and FEV1 %pred in inspiration. Two articles
[18, 22] were excluded because airway measurements
concerned only airways above the fifth airway generation.
Another article [25] was excluded because it did not report
which airways were measured. Four articles [20, 21, 28, 30]
were finally included. The lumen diameter of peripheral
airways was about 2-3 mm in the included articles. The
pooled CC between WA% and FEV1 %pred was -0.59
(95% CI: -0.68, -0.48) in inspiration. Expiratory CT was
not used for airway measurements.
Subgroup analysis and meta-regression
Subgroup analysis for radiation dose was performed for the
association between %LAA-950 and FEV1 %pred in inspi-
ration, indicating no significant difference (P>0.05). In low
dose [18, 19], the pooled CC was -0.44 (95% CI: -0.50,
-0.37). In normal dose [13, 23, 24, 26, 27, 31], the pooled
CC was -0.50 (-0.57, -0.42). Subgroup analysis was also
performed for inspiratory and expiratory CT. A significantly
stronger negative correlation was found between %LAA-
950 and FEV1 %pred in expiratory CT (P<0.05), and a
stronger positive correlation between MLD and FEV1
%pred (P<0.001), but no difference was found in the asso-
ciation between %LAA-950 and FEV1/FVC (P>0.05), or
MLD and FEV1/FVC (P>0.05). In meta-regression for gen-
der contribution, no statistically significant effect modifica-
tion was found for male percentage (P>0.05) (Electronic
supplementary Table 5).
Discussion
In this meta-analysis, significant correlations were found
between CT measurements of emphysema or peripheral
airway and airflow obstruction parameters in PFT in COPD
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Study, Year Correlation (95% CI) Size, n Forest plots Weight,% 
%LAA-950 and FEV1 %pred 
yrotaripsnI
Akira et al, 2009 [13] -0.66 (-0.77, -0.51) 76 10.9 
Bon et al, 2009 [18] -0.43 (-0.53, -0.32) 234 20.6 
Dransfield et al, 2007 [19] -0.44 (-0.52, -0.36) 396 24.8 
Iwasawa et al, 2011 [31] -0.43 (-0.67, -0.12) 35 5.8 
Park et al, 2008 [23] -0.46 (-0.68, -0.17) 39 6.4 
Pauls et al, 2010 [24] -0.36 (-0.49, -0.21) 145 16.4 
Yamashiro et al, 2010 [26] -0.63 (-0.78, -0.41) 46 7.3 
Zhang et al, 2008 [27] -0.52 (-0.70, -0.28) 50 7.9 
Overall, P(Z)<0.001 -0.48 (-0.54, -0.40) 1021 100.0 
Expiratory
Akira et al, 2009 [13] -0.67 (-0.78, -0.52) 76 50.0 
Lee et al, 2008 [22] -0.55 (-0.75, -0.26) 34 21.0 
Yamashiro et al, 2010 [26] -0.64 (-0.78, -0.43) 46 29.0 
       Overall, P(Z)<0.001 -0.64 (-0.72, -0.53) 156 100.0 
Subgroup Analysis, P<0.05*
%LAA-950 and FEV1/FVC 
yrotaripsnI
Akira et al, 2009 [13] -0.71 (-0.81, -0.58) 76 14.7 
Dransfield et al, 2007 [19] -0.58 (-0.64,  0.51) 396 29.2 
Hesselbacher et al, 2011 [29] -0.73 (-0.81, -0.63) 224 17.5 
Iwasawa et al, 2011 [31]  -0.49 (-0.71, -0.19) 35 8.3 
Park et al, 2008 [23] -0.67 (-0.81, -0.45) 39 9.0 
Yamashiro et al, 2010 [26] -0.71 (-0.83, -0.53) 46 10.3 
Zhang et al, 2008 [27] -0.63 (-0.77, -0.42) 50 11.0 
   Overall, P(Z)<0.001 -0.65 (-0.71, -0.58) 866 100.0 
   Expiratory
Akira et al, 2009 [13] -0.67 (-0.78, -0.52) 76 62.9 
Yamashiro et al, 2010 [26] -0.73 (-0.84, -0.56) 46 37.1 
       Overall, P(Z)<0.001 -0.69 (-0.78, -0.59) 122 100.0 
Subgroup Analysis, P>0.05*
MLD and FEV1 %pred 
Inspiratory 
Akira et al, 2009 [13] 0.69 (0.56, 0.80) 76 37.6 
Lee et al, 2008 [22] 0.44 (0.12, 0.68) 34 16.0 
Yamashiro et al, 2010 [26] 0.50 (0.24, 0.69) 46 22.2 
Zhang et al, 2008 [27] 0.42 (0.16, 0.62) 50 24.2 
       Overall, P(Z)<0.001 0.51 (0.38, 0.63) 308 100.0 
   Expiratory 
Akira et al, 2009 [13] 0.79 (0.69, 0.86) 76 41.6 
Lee et al, 2008 [22] 0.62 (0.36, 0.79) 34 26.3 
Yamashiro et al, 2010 [26] 0.66 (0.46, 0.80) 46 32.1 
   Overall, P(Z)<0.001  0.71 (0.58, 0.81) 156 100.0 
Subgroup Analysis, P<0.05*
MLD and  FEV1/FVC 
Inspiratory 
Akira et al, 2009 [13] 0.76 (0.65, 0.84) 76 32.4 
Washko et al, 2009 [25] 0.56 (0.47, 0.65) 224 39.4 
Zhang et al, 2009 [27] 0.51 (0.27, 0.69) 50 28.2 
Overall, P(Z)<0.001 0.64 (0.52, 0.74) 452 100.0 
   Expiratory 
Akira et al, 2009 [13] 0.72 (0.59, 0.81) 76 62.9 
Yamashiro et al, 2010 [26] 0.74 (0.58, 0.85) 46 37.1 
       Overall, P(Z)<0.001 0.73 (0.63, 0.80) 122 100.0 
Subgroup Analysis, P>0.05*
WA% and FEV1 %pred 
yrotaripsnI
Hasegawa et al, 2006 [20] -0.55 (-0.72,-0.33) 52 16.2 
Leader et al, 2008 [21] -0.58 (-0.66, -0.49) 240 30.8 
Ohno et al, 2011 [30] -0.69 (-0.76, -0.61) 186 28.8 
Yamashiro et al, 2010 [28] -0.47 (-0.60, -0.31) 114 24.2 
Overall, P(Z)<0.001 -0.59 (-0.68, -0.48) 592 100.0 
-1.00 -0.50 0.00 0.50 1.00
-1.00 -0.50 0.00 0.50 1.00
-1.00 -0.50 0.00 0.50 1.00
-1.00 -0.50 0.00 0.50 1.00
-1.00 -0.50 0.00 0.50 1.00
*: Subgroups analysis was performed between inspiratory and expiratory CT 
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patients, both in inspiratory and expiratory CT. The range of
absolute correlation coefficients between included CT meas-
urements and airflow obstruction was 0.48 to 0.65 for in-
spiratory CT and 0.64 to 0.73 for expiratory CT. These
results confirm correlations between morphology and func-
tion in COPD patients. The confidence in these findings is
strong, as results were based on high methodological quality
studies without publication bias. Thus, CT provides a quan-
titative morphological method to investigate the principle
components of airway obstruction in COPD, with similar
strength of associations with airflow obstruction for CT
measurements of emphysema and peripheral airways. The
strongest association was found between CT emphysema
measurements and FEV1/FVC, especially in expiratory CT.
Our systematic review demonstrated differing methodolo-
gies for CT quantification and contrasting correlations with
airflow obstruction in COPD patients.
CT quantification reflects pathophysiological changes in
COPD to some degree. The pathological findings of airway
limitation are in airways<2 mm in internal diameter [38].
Such small airways can hardly be measured directly by CT
because of the spatial resolution limit. However, peripheral
airway (≥ 5th generation) wall thickness can be measured as
WA%. Destruction of the lung parenchyma (emphysema)
can be measured as %LAA-950 or MLD. The morpholog-
ical contribution from these two pathological processes is
difficult to distinguish by spirometry, but is important for
COPD research. The morphological information in CT
quantification of the relative predominance of peripheral
airway wall disease or emphysema may in the future allow
more focused treatment of the predominating COPD
phenotype.
This systematic review incorporated ten different CTmeas-
urements. Although a visual score was common in earlier
publications, we did not discuss it, because of its subjective
nature. Perc15 seems an effective measurement for emphyse-
ma, but Perc15 results could not be pooled because of an
insufficient study number. Only three (%LAA-950, MLD
and WA%) of the ten measurements were eventually pooled
because the study number was sufficient to perform a meta-
analysis. We investigated two PFT parameters (FEV1 %pred
and FEV1/FVC) as they are the two most commonly used
functional parameters regarding airway limitation.
In subgroup analysis, associations for inspiratory and expi-
ratory CT findings were compared. Some authors have reported
that CTmeasurements in expiration are more closely correlated
with airflow obstruction than in inspiration [14, 39–41]. Our
results indicate that CT measurements in expiration rather than
in inspiration were more correlated with FEV1 %pred, not with
FEV1/FVC. Whether an additional expiratory CT data acquisi-
tion should be performed for COPD evaluation is debatable.
Expiratory CT exposes patients to additional radiation; howev-
er, with developments in CT technique, the additional dose will
likely decrease. Also, we found low radiation doses did not
change correlations between CTemphysema quantification and
airflow obstruction compared to normal doses. Low-dose CT
can decrease the overall radiation dose for CT quantitative
emphysema evaluation without loss in diagnostic value.
Multiple airway generations were included in the system-
atic review, but only peripheral airways (≥ 5th generation) in
the meta-analysis. Some authors investigated airways from
the third to fifth or sixth generation, and found that the
association between airway wall measurements and PFT
was stronger for higher generations than lower generations
[20, 28]. Therefore, we only pooled results for airways ≥
fifth generation. Some authors reported moderate associa-
tions with larger airways, ranging from -0.39 to -0.54 [18,
42]. In our meta-analysis, the association between wall area
percentage of peripheral airways and FEV1 %pred was
-0.59. One factor to keep in mind is the overestimation of
airway wall thickness, showing a relative increase with each
airway generation [3]. Despite this factor, based on our
pooled results, the association between disease of the more
peripheral airways (≥ 5th generation) and lung function
appears stronger than for lower generation airways (< 5th
generation), suggesting that airway wall thickness measure-
ments on CT should be performed on the smallest airways
visible.
This study confirms significant correlations between CT
measurements and airflow obstruction in COPD. The corre-
lations were in agreement with some expert narrative
reviews [9, 10] and individual studies [14, 15, 39, 42, 43].
Nevertheless, other studies reported weaker associations,
e.g. the National Emphysema Treatment Trial (NETT) study
[12] and the International COPD Genetics Network (ICGN)
study [2]. In NETT and ICGN, predominantly single-slice
CT was used. Since single-slice CT decreases reproducibil-
ity and accuracy [44], this has likely caused the reduced
strength of the correlations.
This study has some limitations. First, no prospective large
cohort with up-to-date CT technology was found as primary
study. The largest study [45] included over 2,000 participants,
but most of the participants had normal lung function. In
inspiratory CT, the number of included articles was relatively
small, but sufficient to perform a reliable meta-analysis. How-
ever, in expiratory CT, some indicators of bias could not be
determined because of the limited number of studies. Second,
we found 64 different quantitative CT measurements in the
Fig. 3 Forest plots for correlations between CT measurements and
airflow obstruction. CI 0 Confidence interval; P(Z) 0 P value of Z test;
FEV1 %pred 0 percentage of the predicted forced expiratory volume in
the first second; FEV1/FVC 0 FEV1 divided by forced vital capacity;
%LAA-950 0 percentage lower attenuation area than -950 HU; MLD 0
mean lung density; Perc15 0 15 percentile point of lung density; WA% 0
wall area percentage
R
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literature. We chose ten for systematic review and three for
meta-analysis. Although the included parameters are repre-
sentative, the other 54 measurements could be valuable to
evaluate COPD. In another way, FEV1 %pred and FEV1/
FVC were selected as airflow obstruction parameters in PFT,
but other parameters in PFT were valuable for evaluating
COPD. Third, mild heterogeneity was found in three correla-
tions in the meta-analysis. A random effects model was used
to compensate for the heterogeneity.
In conclusion, measurements of emphysema and the pe-
ripheral airways on inspiratory and expiratory CT have sig-
nificant correlations with airflow obstruction as accessed by
FEV1 %pred and FEV1/FVC in COPD patients. Thus, CT
provides a quantitative morphological method to investigate
airflow obstruction by emphysema and peripheral airway
disease in COPD.
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